Navigation Links
Gen-Probe Reports Financial Results for First Quarter 2009
Date:4/30/2009

-- Company Posts Non-GAAP EPS of $0.51(1), Excluding $0.02 of Expenses Related to Tepnel Acquisition --

-- Product Sales Increase 11%, or 15% on a Constant Currency(2) Basis --

-- Company Generates Total Revenues of $116.2 Million, Operating Cash

Flows of $52.0 Million --

SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) today reported financial results for the first quarter of 2009, including non-GAAP earnings per share (EPS) of $0.51.

"Gen-Probe posted good financial results in the first quarter of 2009, highlighted by a new record in clinical diagnostics product sales, despite significant foreign exchange headwinds," said Henry L. Nordhoff, the Company's chairman and chief executive officer. "In recent weeks, we also completed our Tepnel acquisition and decided to begin a U.S. clinical trial of our PCA3 prostate cancer test, both of which we expect to drive future growth."

As expected, total revenues and net income declined in the first quarter of 2009 compared to the prior year period because the Company recorded $16.4 million of revenue from Bayer in the first quarter of 2008. This non-recurring revenue, which added $0.20 to EPS in the prior year period, represented the third and final payment due to Gen-Probe in connection with the 2006 settlement of the companies' patent infringement litigation.

In the first quarter of 2009, product sales were $112.5 million, compared to $101.5 million in the prior year period, an increase of 11%. Compared to the first quarter of 2008, the stronger U.S. dollar reduced product sales growth by an estimated 4%. Total revenues for the first quarter of 2009 were $116.2 million, compared to $122.6 million in the prior year period, a decrease of 5%. Net income was $27.0 million ($0.5
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement
2. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
3. Tepnel Shareholders Approve Acquisition by Gen-Probe
4. Gen-Probe Reports Strong Financial Results for Fourth Quarter and Full Year 2008
5. Gen-Probe to Acquire Tepnel Life Sciences, Fast-Growing European Molecular Diagnostics Company, for 92.8 Million Pounds Sterling ($132.2 Million) in Cash
6. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
7. Eric Tardif Joins Gen-Probe as Senior Vice President, Corporate Strategy
8. Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
9. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
10. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
11. Gen-Probe Announces Webcasts of Three Upcoming Investor Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 01, 2015 Tempaper has joined forces ... virtual giving campaign that will raise critical funds to ... muscle disease across the United States. , Throughout the ... Tempaperdesigns.com will automatically receive free domestic ground ... and urgently needed progress to children and adults affected ...
(Date:4/1/2015)... FL (PRWEB) April 01, 2015 IQ ... growing health and nutritional supplement companies in the U.S., today ... the testing and quality control standards for its herbal supplements.* ... the supply chain to ensure the accuracy of labeling on ... industry veteran and IQ Formulations CEO Jay Cohen ...
(Date:4/1/2015)... April 01, 2015 When annoying or ... waiting days or weeks for an appointment with a ... and next day appointments haven’t been possible within dermatology. ... Dermatology’s offices have noticed demand for this level of ... realize how important relief or answers to dermatological issues ...
(Date:4/1/2015)... The 2015 Deep Market Research ... professional and in-depth study on the current state ... with a focus on the Chinese situation. , ... are Pfizer, Lek Pharmaceuticals D.D., Dr Reddys Labs ... Limited, Cadila Healthcare Limited, Sandoz Inc, Teva Pharms, ...
(Date:4/1/2015)... New York, NY (PRWEB) April 01, 2015 ... currently reports there are “more than 123,000 patients who ... may not be aware of this surprising statistic. ... to Donate Life” PSA, Erik Compton, a PGA TOUR ... organ donation and encourages Americans to become organ donors. ...
Breaking Medicine News(10 mins):Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2
... ... support to the Major League Baseball Players Alumni association to raise ... and auction, helps provide hope and funding for end stage cancer ... and life for cancer patients and their families. Providing financial assistance ...
... ... progress but says there are still too many preventable automobile accidents. , ... New York, NY (PRWEB) April 23, 2010 -- ... become complacent to driving hazards as they hit the highway for a summer vacation road ...
... Cancer is the number-one ... Buffalo are partnering to raise awareness and funds to fight this devastating disease. The goal this ... Foundation to fund research and finding a cure. , ... Wilton, Conn., and San Diego (PRWEB) April 24, 2010 -- Cancer is ...
... He Volunteered ... His Experience to Further the Search for a Cure and Better Treatments for PD. ... (PRWEB) -- “Deep Brain Diary: ... personal story about living with a neurological disease that afflicts over a million Americans. ...
... ... to grow enormously over the next few years and healthcare related jobs ... greater employment opportunities for those individuals educated and trained in any of ... generation will bring with it a strong demand for skilled medical workers, ...
... Groundbreaking move ... data.worldbank.org. , ... April 22, 2010 -- The World Bank Group announced on Tuesday that it has thrown ... to use the data to create new applications and solutions to help poor people in ...
Cached Medicine News:Health News:Major League Baseball Players Alumni Help Lazarex Cancer Foundation Raise Funds 2Health News:Major League Baseball Players Alumni Help Lazarex Cancer Foundation Raise Funds 3Health News:U.S. and New York Car Accident Deaths Continue Steady Decline 2Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 2Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 3Health News:BLUE Buffalo Pet Food and PETCO Partner to Fight Pet Cancer During Pet Cancer Awareness Month 4Health News:Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research 2Health News:Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research 3Health News:Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research 4Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 2Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 3Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 4Health News:Prospective Healthcare Workers: Fully Accredited Healthcare Degree Programs Are Now Offered Through OnlineEducation.com 5Health News:World Bank Group Opens Data to All 2
(Date:4/1/2015)... 2015 LifeScienceIndustryResearch.com announces ... Industry and 2015 Deep Research Report on ... Pharmaceutical category in its database.  ... basic information, including definition, classification, application, industry ... news analysis, etc. Azithromycin Key Manufacturers Analysis ...
(Date:4/1/2015)... -- Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" or the ... chairman and executive director purchased 40,000,000 ordinary shares (the ... entire issued share capital of the Company from AMG ... amount of approximately HK$113 million. Upon the completion of ... 45.17% to 47.17%. Mr. Jin Dongtao, ...
(Date:4/1/2015)... and Markets ( http://www.researchandmarkets.com/research/n9mxqs/an_introduction ) has announced ... Medical Device Directives" conference to their offering. ... European medical device legislation. It will explain the Directives ... Bodies, how to choose one and outline what a ... necessary to apply for the CE mark. ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2
... Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm developing ... infections, announced today the completion of enrollment for a ... vaccine is being developed for use in uninfected people ... virus. The trial, designated HVTN 205, is being conducted ...
... Inc. (NASDAQ: VVUS ) today announced that ... th Annual Scientific Meeting of The Obesity Society ... long-term beneficial effects of Qnexa ® treatment in ... significant improvement in liver function and reductions in medications ...
Cached Medicine Technology:GeoVax Phase 2a Clinical Trial Completes Enrollment 2GeoVax Phase 2a Clinical Trial Completes Enrollment 3GeoVax Phase 2a Clinical Trial Completes Enrollment 4Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 2Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 3Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 4Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 5Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 6
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... P.M.® lets you sleep on ... in the morning awake with ... ready to take on the ... comfort and protection, this preservative-free ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: